Consignees were notified via Urgent Medical Device Recall letter on April 21, 2017. The letter identified the affected product, problem and actions to be taken. They were instructed to discontinue use and quarantine any products with the affected catalog numbers and lot numbers. They were to return the product, complete the enclosed Recall Acknowledgement Form and fax it to the
Attn: Customer Service or email to recalls@teleflex.com. A Recall Acknowledgment
Form was enclosed to be completed and returned via fax even if they have no stock.
Initiated
2017-04-21
Root cause
Labeling False and Misleading
Terminated
2020-01-27
Distribution
Worldwide Distribution - U.S. Nationwide. Foreign consignees: Australia, Canada, China, Columbia, India, San Salvador, Singapore and South Korea.
Recall number
Z-2130-2017
Recall status
Terminated
CDRH record ID
154939
FDA record created
2017-05-22
Recall event number
77081
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.